Ono Pharmaceutical
1717
51
50
109
ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents on prescription pharmaceuticals. The company focuses on drug discovery leads that are high in certainty and globally competitive.
The company was started in 1717 in Dosho-machi, Osaka. Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.
R&D Platform
ONO has discovered new drug discovery seeds and developed breakthrough new drugs initiated through collaboration with research institutes including universities since before the words “open innovation” started to become widely used. With Discovery Research Alliance and Corporate Development & Strategy Business Development taking the lead, we continue to pursue drug discovery collaborations and vigorous compound licensing activities with world top-class researchers and biopharmaceutical companies mainly in the priority areas of research. We also pursue collaboration activities with speed to collect cutting-edge scientific information and proceed with drug discovery based thereon ahead of the competition as fast as possible. We post employees with extensive experience in discovery research to our overseas subsidiaries in the US and UK, and they visit world top-class researchers and biopharmaceutical companies in the US and Europe to launch alliances.